(Q46742939)

English

Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

author name string

Ying Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Depei Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Aining Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Zhengming Jin

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Huiying Qiu

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Miao Miao

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Xiaowen Tang

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Zhengzheng Fu

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

publication date

22 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

87

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

167-171

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

https://scigraph.springernature.com/pub.10.1007/s12185-008-0032-4

0 references

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prior exposure to imatinib on transplant-related mortality.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib therapy prior to myeloablative allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18288566

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-008-0032-4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

release_iaqqcfzkrnc45ff2tb4syzddzm

1 reference

https://api.fatcat.wiki/v0/release/iaqqcfzkrnc45ff2tb4syzddzm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18288566

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46742939&oldid=2129554234"